Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive after announcing an extension of the company's existing collaboration with AnaBio Technologies by agreeing to collaborate with AnaBio's sister company InsuCaps to looks at developing treatments for metabolic diseases. Skillington describes it as a "terrific opportunity" for Poolbeg.
Poolbeg Pharma makes "interesting addition to existing collaboration"
